PMBS Stock UPDATES Puramed Bioscience (PMBS) 0.0001 10/29/2014

New Post Public Reply Private Reply Replies (0) Message Board

Oct 29, 2014 at 3:13 PM

Puramed Bioscience (PMBS) 0.0001 $PMBS

PuraMed BioScience Completes the First Production of MigraPure® Gel
PR Newswire - Wed Aug 13, 11:28AM CDT
PuraMed BioScience®, Inc., (OTCPink

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company has completed its first batch of its patented, sublingual MigraPure® gel containing feverfew and ginger with an enhanced flavor.

PuraMed BioScience to add Cannabis-based epilepsy medication to its product line
M2 - Wed Aug 06, 5:53AM CDT
OTC medicinal company PuraMed BioScience (Other OTC

MBS) said on Tuesday that it intends to begin testing a new hemp-based epilepsy medication in the fourth quarter of 2014.

PuraMed BioScience Develops a Cannabis-based Epilepsy Medication
PR Newswire - Tue Aug 05, 1:00PM CDT
PuraMed BioScience®, Inc., (OTCPink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it plans to begin testing of a new hemp-based epilepsy medication in the fourth quarter of 2014.

PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M
PR Newswire - Wed Jul 30, 12:57PM CDT
PuraMed BioScience®, Inc., (OTCPink

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with the name's red and yellow logo. The former will be replaced with the trademarked name MigraPure® going forward. The new name, logo, and color palette of PuraMed's homeopathic, natural migraine pain reliever will be reintroduced into selected segments of the retail marketplace.

PuraMed BioScience forms corporate sponsor partnership with Operation Troop Aid for US military
M2 - Wed Jul 23, 7:38AM CDT
Healthcare company PuraMed BioScience (PNK

MBS) reported on Tuesday the launch of a corporate sponsor agreement with Operation Troop Aid in aid of the US military.

PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages
PR Newswire - Tue Jul 22, 7:49AM CDT
PuraMed BioScience®, Inc., (OTCBB: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is a corporate sponsor of Operation Troop Aid.

PuraMed BioScience Announces Product Donation at a Sponsorship Level to Operation Gratitude
PR Newswire - Tue Jul 08, 8:11AM CDT
PuraMed BioScience®, Inc., (OTCBB

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is now a corporate sponsor of Operation Gratitude.

PuraMed BioScience Explores the Development of Hemp and THC-Free Cannabis Formulations to Expand Its Product Line
PRWeb - Mon Mar 24, 6:09AM CDT
PuraMed BioScience(R), Inc., (OTCBB

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, confirmed today that it is seriously exploring the development of cannabinoid and hemp-based formulations to expand its natural and homeopathic product line.

Energy Utilities Focus on Providing Reliable and Safe Service while Meeting Compliance Standards
PR Newswire - Wed Feb 26, 7:00AM CST
To streamline and standardize gas compliance processes and adapt to the demands of the energy service and delivery industry, Ameren Corporation has turned to the mobile workforce management market leader, ClickSoftware Technologies Ltd. (NasdaqGS: CKSW). The implementation of ClickSoftware's scheduling and mobility offering for gas compliance processes will eliminate paper inspection forms and improve data quality, improve flexibility to adapt to rapidly changing regulatory requirements, and provide management with greater visibility into compliance activities.
CKSW: 6.99 (-0.06), AEE: 41.16 (-0.51)

Merger Approval, Financial Results, Conference Call Schedule, and Stock Price Updates - Research Report on Omnicom, Global Payments, FleetCor, Interpublic, and Fiserv
PR Newswire - Wed Jan 15, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
OMC: 69.99 (-0.02), GPN: 79.46 (-0.65), FISV: 67.62 (+0.36), IPG: 18.87 (-0.06), FLT: 139.96 (-0.31)

PuraMed BioScience Invited to Discuss LipiGesic M on Armed Forces Network
PR Newswire - Thu Aug 29, 11:03AM CDT
PuraMed BioScience®, Inc., (OTCBB

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced that it will discuss LipiGesic M on Armed Forces Network.

PuraMed BioScience Sponsors Miles for Migraine Race with LipiGesic M
PR Newswire - Thu Aug 22, 7:00AM CDT
PuraMed BioScience®, Inc., (OTCBB

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it will sponsor the 5th Miles for Migraine Race San Francisco by supplying $5,000 of LipiGesic M for the participants.

PuraMed BioScience Inc signs LipiGesic M distributor agreement with OuterBanks Outdoors
M2 - Thu Aug 15, 10:13AM CDT
Healthcare company PuraMed BioScience Inc (OTC BB

MBS) reported on Wednesday the launch of an exclusive distribution agreement to sell LipiGesic M on Amazon.com..

PuraMed BioScience Announces Distributor Agreement with OuterBanks Outdoors
PR Newswire - Wed Aug 14, 1:08PM CDT
PuraMed BioScience®, Inc., (OTCBB

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it has entered into an exclusive distribution agreement with OuterBanks Outdoors to sell LipiGesic® M, its homeopathic formulation of feverfew and ginger for treatment of acute migraine, on Amazon.com.

LipiGesic M is the only recommended first-line therapy for acute migraine that has no evidence of rebound headache
PR Newswire - Mon Aug 05, 2:44PM CDT
PuraMed BioScience®, Inc., (OTCBB

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, confirmed today that its product, LipiGesic® M, a homeopathic formulation of feverfew and ginger that eliminates migraine pain and associated symptoms, is the only recommended first-line therapy for acute migraine in the retail market today that has shown no evidence of rebound or medication-overuse headache.

PuraMed BioScience Inc reports 42.6m outstanding shares in issue
M2 - Wed Jul 03, 4:36AM CDT
Medicinal products company PuraMed BioScience Inc (OTC BB

MBS) declared on Tuesday that its current common shares issued and outstanding totalled 42,610,297 as of 30 June 2013.

PuraMed BioScience Announces Common Shares Outstanding of 42.6 Million
PR Newswire - Tue Jul 02, 10:27AM CDT
PuraMed BioScience®, Inc., (OTCBB: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announces update of current share structure.

PuraMed BioScience® Announces Science Behind LipiGesic® M Migraine Treatment
PR Newswire - Fri Jun 21, 10:05AM CDT
PuraMed BioScience®, Inc., (OTCBB

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced the science behind LipiGesic® M, its homeopathic, over-the-counter migraine medication.

PuraMed BioScience® Announces Interview on Big Biz Show Discussing LipiGesic® M
PR Newswire - Mon Jun 10, 7:00AM CDT
PuraMed BioScience®, Inc., (OTCBB

MBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced an interview conducted on Big Biz Show with PuraMed BioScience's CEO Russ Mitchell to discuss and inform listeners about PuraMed BioScience's flagship product, LipiGesic® M.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Biointron's RushDATA™: Speeding Up Antibody Discovery

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

Bernard Lancaster Steps Up as Mammoth's New President

A New Era Under Bernard Lancaster at Mammoth Change is in the air for Mammoth Energy Services, as Bernard “Bernie” Lancaster takes the helm as President. His promotion on November 9, 2026, might not send shockwaves through Wall Street right away, but anyone holding an interest in NASDAQ:TUSK should take note. Lancaster's appointment is the kind of decision that...

Microsoft's Cloud Misstep: Recovery Plans in Focus

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Longsys and Lexar Push Boundaries in Edge AI Storage

Longsys and Lexar: A Revolution in Storage Ah, the tech world—it's like a fast-moving express train you just can't afford to miss. Longsys and its sidekick Lexar are in the spotlight this time, and boy, they've got some head-turning announcements. At electronica 2026 in Munich, they're playing the storage game hard. From industrial-grade mSSD to automotive solutions,...

Worker.ai Acquires DeltaGen to Spice Up SMB Growth

Betting Big on Small Business If you've ever run a small business, you know it can feel like a hamster wheel—more customers usually mean more headaches. But here comes Worker.ai, stepping onto the scene with big promises and a fancy new acquisition. They've scooped up DeltaGen—a mover in real-time AI tech—and launched a platform to hand these overworked owners a...

Global Case Studies in Poverty Reduction Spotlighted

A Fresh Spotlight on Poverty Reduction Efforts Amid the clamor of social and economic challenges, 126 stellar case studies of poverty reduction just took center stage at a seminar in Beijing. These admired initiatives emerged from the seventh global solicitation, chosen from a pile of 890 entries submitted by do-gooders and organizations spanning 31 countries. If you've...

Odessa Water Overbilling Lawsuit Surges Ahead

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

ACR Poker's $20M OSS: Stakes High on Sunday Action

ACR Poker Takes the Spotlight with a Mammoth Sunday Sunday, November 15 is about to be a slugfest over at ACR Poker, as players gear up for an intense day of card-shuffling and betting. We’re looking at flights for all four headlining events of the Online Super Series (OSS) right alongside day two of The Quattro and an eye-popping WSOP Paradise Mega Satellite blowing...

WeFetch AI: A New Era in Barcode Precision

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...